Steven M. Paul

Former Venture Partner at Third Rock Ventures LLC

Steven M. Paul

Steven M. Paul

Former Venture Partner at Third Rock Ventures LLC

Overview
Career Highlights

The American College of Neuropsychopharmacology, Inc.
Lilly Research Laboratories
Eli Lilly & Company

RelSci Relationships

8329

Number of Boards

31

Birthday

1951

Age

70

Number of Awards

3

Contact Data
Trying to get in touch with Steven M. Paul? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Steven M. Paul likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Kew, Inc.

Relationship likelihood: Strong

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Chief Business Officer at Akili Interactive Labs, Inc.

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Chief Innovation Officer at SAGE Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Karuna Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Director at National Institutes of Health

Relationship likelihood: Strong

President & Chief Executive Officer at Verity BioConsulting LLC

Relationship likelihood: Strong

Paths to Steven M. Paul
Potential Connections via
Relationship Science
You
Steven M. Paul
Former Venture Partner at Third Rock Ventures LLC
Family Members
Child
Fellow, Neuroradiology at The Massachusetts General Hospital

Since 1811, Massachusetts General Hospital has been committed to delivering standard-setting medical care. Throughout the decades, the hospital has had a consistent commitment to advancing that care through pioneering research and educating future health care professionals. The third oldest general hospital in the United States and the oldest and largest hospital in New England, Mass General continues its tradition of excellence today. On July 17, 2012, Mass General was named America's best hospital by U. S. News & World Report based on our quality of care, patient safety and reputation in 16 different specialties. In 2008, Mass General was redesignated a Magnet hospital, the highest honor for nursing excellence awarded by the American Nurses Credentialing Center. World-Class Patient Care Our 907-bed medical center, located in the heart of Boston, offers sophisticated diagnostic and therapeutic care in virtually every specialty and subspecialty of medicine and surgery. We offer high-quality care and services in four health centers in the Boston area. The hospital also holds concurrent Level 1 verification for adult and pediatric trauma and burn care. Our five multidisciplinary care centers – known worldwide for innovations in cancer, digestive disorders, heart disease, transplantation and vascular medicine – unite specialists across the hospital to offer patients comprehensive, state-of-the-art medical care. In addition, through MassGeneral Hospital for Children, we provide a full range of pediatric health care services, from primary care to cutting-edge treatments of complex and rare disorders. A Research Powerhouse Mass General has long been a leader in successfully bridging innovative science with state-of-the-art clinical medicine. With an annual research budget of nearly $764 million, Mass General conducts the largest hospital-based research program in the United States - a program that spans more than 20 clinical departments and centers across the hospital. This funding drives discoveries and breakthroughs in basic and clinical research, which translate into new and better treatments that transform medical practice and patient care. Learn more about Mass General research. An Emphasis on Teaching Mass General is the original and largest teaching hospital of Harvard Medical School, where nearly all of our staff physicians serve on the faculty. Since the hospital’s founding, Mass General has been committed to training and mentoring the next generation of international leaders in science and medicine, providing a wealth of opportunities for physicians, nurses, allied health professionals, physical, occupational and speech and language therapists and other health professionals. These talented men and women, in turn, lend fresh and innovative perspective on how to treat and care for patients. See medical residency and fellowship opportunities at Mass General. Setting the Bar for Quality & Safety Safety, effectiveness, patient centeredness, timeliness, efficiency and equity – these six tenets established by the Institute of Medicine are the foundation of our approach to quality and safety. We measure our performance, set high goals and track our progress toward those goals. We compare ourselves against local and national benchmarks in key quality and safety areas to ensure we deliver the highest quality and safest care possible. Learn more about our quality and patient-safety programs. Reaching Out to the Community Our work has always been guided by the needs of patients and their families. Mass General partners with communities to build, improve and sustain health care delivery and increase the health and well-being of those who live and work and these communities. Read about how Mass General is making a difference locally and globally. At our main campus and four health centers in Charlestown, Chelsea, Revere and the North End, Mass General annually: Admits 47,000 inpatients Handles nearly 1.4 million outpatient visits Records 88,000 emergency room visits Performs 38,000 operations Delivers 3,600 babies Mass General is a founding member of Partners HealthCare, an integrated health care delivery system that includes the two founding academic medical centers, community hospitals, primary care and specialty physicians, specialty facilities, community health centers and other health-related entities. Our Mission Guided by the needs of our patients and their families, we aim to deliver the very best health care in a safe, compassionate environment; to advance that care through innovative research and education; and to improve the health and well-being of the diverse communities we serve

Education
MS
Class of 1975

Tulane University is a private, nonsectarian research university located in New Orleans, Louisiana, United States. Founded as a public medical college in 1834, the school grew into a comprehensive university in 1847 and was eventually privatized under the endowments of Paul Tulane and Josephine Louise Newcomb in 1884. Tulane is a member of the Association of American Universities.

MD
Class of 1975

The Tulane University School of Medicine is located in New Orleans, Louisiana, USA and is a part of Tulane University. The school is located in the Medical District of the New Orleans Central Business District. The school was founded in 1834 as the Medical College of Louisiana and is the 15th oldest medical school in the United States and the 2nd oldest in the deep south. The first classes were held in 1835 at a variety of locations, including Charity Hospital and the Strangers Unitarian Church.

Memberships
Fellow
2009 - Current

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

Member
Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Member
Current

Alpha Omega Alpha supports many programs for medical students and physicians at our 123 chapters, and publishes a quarterly journal, The Pharos, which contains articles on nontechnical medical subjects, including history, ethics, national issues, personal essays, and poetry.

Career History
Chairman of the Board, President & Chief Executive Officer
2018 - Current

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders.The company was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.

Co-Founder
2011 - Current

Tal Medical, Inc. operates as a clinical stage medical device company. It develops novel, non contact, neuromodulatory devices for the treatment of psychiatric and neurological disorders. The firm focuses on the development of LFMS for the treatment of major depressive disorder and bipolar depression. The company was founded by Daphne Zohar, Steven Marc Paul, Andrew Miller, Eric Elenko and Nessan Bermingham in 2010 and is headquartered in Boston, MA.

Venture Partner
2010 - Current

Third Rock Ventures invests in companies located in the US. The firm targets operating in the fields of healthcare sector. It provides financing for early-stage capital requirements. It also acts as a lead investor.

Boards & Committees
Member, Board of Directors
Prior

BioCrossroads focuses on early-stage investments in invests in life sciences opportunities including healthcare informatics, biotechnology manufacturing, agribiotechnology, pharmaceuticals, diagnostics and medical devices. Their objective is to create new jobs and introduce new business opportunities in the state of Indiana.The Indiana Seed Fund I is a seed-stage private investment that provides pre-venture investment capital to emerging, start-up life sciences companies in Indiana. The Fund is a return-driven fund that makes direct equity investments of $50,000 to $500,000.The Indiana Future Fund seek to build an overall investment portfolio with: (1) approximately 60% of its investments placed through Indiana-focused or Indiana-based venture capital funds (2) approximately 70% of its investments made in funds that intend to invest in early-stage or seed-stage companies (3) approximately 60% of its investments are made in Indiana-based companies and (4) approximately 60% of its investments are made in the life sciences sector.

Director
Tenure Unconfirmed

Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA.

Director
2001 - 2006

NIH is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions in every state across America and around the globe. NIH is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. NIH leadership plays an active role in shaping the agency's research planning, activities, and outlook. The Office of the Director is the central office at NIH, responsible for setting policy for NIH and for planning, managing, and coordinating the programs and activities of all the NIH components. The NIH Director, with a unique and critical perspective on the entire agency, is responsible for providing leadership to the Institutes and for constantly identifying needs and opportunities, especially for efforts that involve multiple Institutes. The NIH Director is assisted by the NIH Deputy Directors including the Principal Deputy Director, who shares in the overall direction of the agency's activities. NIH is responsive to Congressional legislation that adjusts NIH's programs to meet changing research needs. As a result of the NIH reauthorization process, NIH is able to respond strategically in an era when medical research requires constant innovation and increased interdisciplinary efforts. More than 80% of the NIH's budget goes to more than 300,000 research personnel at over 2,500 universities and research institutions. In addition, about 6,000 scientists work in NIH’s own Intramural Research laboratories, most of which are on the NIH main campus in Bethesda, Maryland. The main campus is also home to the NIH Clinical Center, the largest hospital in the world totally dedicated to clinical research. Successful biomedical research depends on the talent and dedication of the scientific workforce. NIH supports many innovative training programs and funding mechanisms that foster scientific creativity and exploration. The goal is to strengthen our nation’s research capacity, broaden our research base, and inspire a passion for science in current and future generations of researchers. NIH encourages and depends on public involvement in federally supported research and activities. NIH’s wide-ranging public efforts include outreach and education, nationwide events, requests for public input on NIH projects, and special programs designed specifically to involve public representatives in clinical research

Board Member
Prior

The Eli Lilly and Company Foundation is a tax-exempt private foundation established by the company in 1968. The Foundation awards cash grants for philanthropic initiatives aligned with the company's corporate responsibility priorities.

Council Member
Prior

American College of Neuropsychopharmacology is an American nonprofit company located in Brentwood, TN, that operates as a neuron psychopharmacology school.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$50K - $100K
2017

The Foundation leverages NIH's science with private-sector support for biomedical advances that benefit people around the world. As a non-profit organization, the Foundation serves donors who wish to support biomedical research by building on the resources and talent at NIH in specific areas of interest. In addition, the Foundation supports training and advanced education programs for the investigators of tomorrow and invests in educational programs about medical research.

$10K - $25K
2017

The Alzheimer’s Drug Discovery Foundation was established in 2004 as a public charity to support the advancement of drugs to prevent, treat, and cure Alzheimer’s disease, related dementias, and cognitive aging. This strategy of venture philanthropy is based on the idea that research grant recipients are engaged in projects that are potentially viable in the marketplace with a possible return on investment.

$50K - $100K
2016

The Foundation leverages NIH's science with private-sector support for biomedical advances that benefit people around the world. As a non-profit organization, the Foundation serves donors who wish to support biomedical research by building on the resources and talent at NIH in specific areas of interest. In addition, the Foundation supports training and advanced education programs for the investigators of tomorrow and invests in educational programs about medical research.

Transactions
Details Hidden

Voyager Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Tal Medical, Inc. raised money in a private placement transaction

Details Hidden

Eli Lilly & Company purchases Hypnion, Inc.

Investments
Details Hidden

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders.The company was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.

Details Hidden

SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.

Details Hidden

Tal Medical, Inc. operates as a clinical stage medical device company. It develops novel, non contact, neuromodulatory devices for the treatment of psychiatric and neurological disorders. The firm focuses on the development of LFMS for the treatment of major depressive disorder and bipolar depression. The company was founded by Daphne Zohar, Steven Marc Paul, Andrew Miller, Eric Elenko and Nessan Bermingham in 2010 and is headquartered in Boston, MA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Board Certification - American Board of Psychiatry and Neurology
A. E. Bennett Award
Arthur S. Flemming Award
Events
Speaker
New York City, NY
4th Annual Partnering for Cures

Partnering for Cures is FasterCures' annual meeting that brings together diverse participants to discuss and solve the crucial issues facing the medical research world today. Partnering for Cures is structured with thought-provoking panels that host well-known speakers from the different sectors of the medical world; presenters from organizations that are boasting innovative approaches to the issues facing health; pro-bono, personalized advice from experts across medical research fields; and a unique partnering systems that allows conference participants to schedule meetings throughout the weekend to collaborate and create new approaches to save and improve lives.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Steven M. Paul. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Steven M. Paul's profile does not indicate a business or promotional relationship of any kind between RelSci and Steven M. Paul.